Files in this item
Author | Sigounas, George | |
Author | Mehlhop, Paul | |
Date Accessioned | 2019-11-11T18:37:56Z | |
Date Available | 2019-11-11T18:37:56Z | |
Date of Issue | 2002-10-17 | |
Identifier (Other) | Canada Patent # CA2443025A1 | |
Identifier (Other) | US Pat# US28262101P | |
Identifier (URI) | http://hdl.handle.net/10342/7535 | |
Description | Application abandoned? | en_US |
Description | A method of reducing organ toxicity in a subject being administered a cytotoxic agent comprising concurrently administering with the cytotoxic agent erythropoietin (EPO), the EPO being administered in an amount effective to reduce pulmonary toxicity caused by the cytotoxic agent. | en_US |
Language | en_US | en_US |
Related URI | https://patents.google.com/patent/CA2443025A1/en?oq=inassignee:%22East+Carolina%22 | en_US |
Subject | cytotoxicity | en_US |
Title | Erythropoietin ameliorates chemotherapy-induced toxicity in vivo | en_US |
Type | Patent | en_US |